125 related articles for article (PubMed ID: 38134838)
21. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors.
Mardekian SK; Solomides CC; Gong JZ; Peiper SC; Wang ZX; Bajaj R
J Clin Lab Anal; 2015 Nov; 29(6):462-8. PubMed ID: 25132285
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma].
Chen C; He X; Jing WY; Qiu Y; Chen M; Luo TY; Liu XY; Chen HJ; Zhang HY; Bu H
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):190-195. PubMed ID: 35249280
[No Abstract] [Full Text] [Related]
24. Dysplastic lipoma: potential diagnostic pitfall of using MDM2 RNA in situ hybridization to distinguish between lipoma and atypical lipomatous tumor.
Hung YP; Michal M; Dubuc AM; Rosenberg AE; Nielsen GP
Hum Pathol; 2020 Jul; 101():53-57. PubMed ID: 32439322
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
26. Detection of
Rekhi B; Karnik N; Agrawal R; Shetty O; Patkar S
Indian J Pathol Microbiol; 2022; 65(1):65-75. PubMed ID: 35074968
[TBL] [Abstract][Full Text] [Related]
27. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
28. Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma.
Weaver J; Goldblum JR; Turner S; Tubbs RR; Wang WL; Lazar AJ; Rubin BP
Mod Pathol; 2009 Jan; 22(1):66-70. PubMed ID: 18836421
[TBL] [Abstract][Full Text] [Related]
29. Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults.
Zhang G; Lanigan CP; Goldblum JR; Tubbs RR; Downs-Kelly E
Arch Pathol Lab Med; 2016 Oct; 140(10):1111-5. PubMed ID: 27684983
[TBL] [Abstract][Full Text] [Related]
30. Silver In Situ Hybridization for the Rapid Assessment of MDM2 Amplification in Soft Tissue and Bone Tumors. Validation Based on an Audit of 192 Consecutive Cases Evaluated by Silver In Situ Hybridization and Fluorescence In Situ Hybridization.
Farshid G; Otto S; Collis M; Napper S; Nicola M
Appl Immunohistochem Mol Morphol; 2023 Feb; 31(2):101-106. PubMed ID: 36692149
[TBL] [Abstract][Full Text] [Related]
31. Overexpression and amplification of Murine double minute 2 as a diagnostic tool in large lipomatous tumor and its correlation with Ki67 proliferation index: an institutional experience.
Putri RI; Siregar NC; Siregar B
Indian J Pathol Microbiol; 2014; 57(4):558-63. PubMed ID: 25308007
[TBL] [Abstract][Full Text] [Related]
32. Intra-Abdominal and Retroperitoneal Benign Lipomatous Tumors-An Extremely Rare Mimic of Liposarcoma and its Diagnostic Challenge.
Malik F; Allbee AW; Zhang PJ
Int J Surg Pathol; 2024 Feb; 32(1):46-57. PubMed ID: 37131332
[No Abstract] [Full Text] [Related]
33. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
[TBL] [Abstract][Full Text] [Related]
34. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
Machado I; Vargas AC; Maclean F; Llombart-Bosch A
Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
[TBL] [Abstract][Full Text] [Related]
35. Biology and Management of Deep-seated Atypical Lipomatous Tumor of the Extremities.
Nishio J; Nakayama S; Chijiiwa Y; Aoki M
Anticancer Res; 2023 Oct; 43(10):4295-4301. PubMed ID: 37772567
[TBL] [Abstract][Full Text] [Related]
36. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?
Weaver J; Rao P; Goldblum JR; Joyce MJ; Turner SL; Lazar AJ; López-Terada D; Tubbs RR; Rubin BP
Mod Pathol; 2010 Oct; 23(10):1301-6. PubMed ID: 20495536
[TBL] [Abstract][Full Text] [Related]
37. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
38. MDM2 analysis in the management of benign lipomas versus atypical lipomatous tumors/well-differentiated liposarcomas: A useful prognostication tool?
Choi KY; Mack L; Caragea M; Monument M; Puloski S; Bouchard-Fortier A
Am J Surg; 2022 Aug; 224(2):747-750. PubMed ID: 35397923
[TBL] [Abstract][Full Text] [Related]
39. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.
Gardner JM; Dandekar M; Thomas D; Goldblum JR; Weiss SW; Billings SD; Lucas DR; McHugh JB; Patel RM
Am J Surg Pathol; 2012 Jul; 36(7):1047-51. PubMed ID: 22472959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
